News

Capital Brief51m
Sanofi to buy Vicebio in US$1.6b deal for Aussie-developed vaccine tech
Sanofi is acquiring UK biotechnology company Vicebio for up to US$1.6 billion ($2.4 billion) in the largest deal involving a ...